These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 1690210

  • 21. Oncogene-mediated transformation of fetal rat colon in vitro.
    Pories S, Jaros K, Steele G, Pauley A, Summerhayes IC.
    Oncogene; 1992 May; 7(5):885-93. PubMed ID: 1373876
    [Abstract] [Full Text] [Related]

  • 22. Ki-ras activation and expression in transformed mouse lung cell lines.
    Pan YH, Nuzum EO, Hanson LA, Beer DG.
    Mol Carcinog; 1990 May; 3(5):279-86. PubMed ID: 2244960
    [Abstract] [Full Text] [Related]

  • 23. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation.
    Ibson JM, Rabbitts PH.
    Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684
    [Abstract] [Full Text] [Related]

  • 24. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ, Robinson RA, Haddad SF, Moore SA.
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [Abstract] [Full Text] [Related]

  • 25. Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.
    Slebos RJ, Evers SG, Wagenaar SS, Rodenhuis S.
    Br J Cancer; 1989 Jan; 59(1):76-80. PubMed ID: 2547415
    [Abstract] [Full Text] [Related]

  • 26. DNA alterations at proto-oncogene loci and their clinical significance in operable non-small cell lung cancer.
    Hajj C, Akoum R, Bradley E, Paquin F, Ayoub J.
    Cancer; 1990 Aug 15; 66(4):733-9. PubMed ID: 2167142
    [Abstract] [Full Text] [Related]

  • 27. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
    Milo GE, Shuler C, Kurian P, French BT, Mannix DG, Noyes I, Hollering J, Sital N, Schuller D, Trewyn RW.
    Proc Natl Acad Sci U S A; 1990 Feb 15; 87(4):1268-72. PubMed ID: 2406716
    [Abstract] [Full Text] [Related]

  • 28. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
    Harvey WH, Harb OS, Kosak ST, Sheaffer JC, Lowe LR, Heerema NA.
    Leuk Res; 1994 Aug 15; 18(8):577-85. PubMed ID: 7520517
    [Abstract] [Full Text] [Related]

  • 29. Proto-oncogene and growth factor/receptor expression in the establishment of primary human non-small cell lung carcinoma cell lines.
    Liu C, Tsao MS.
    Am J Pathol; 1993 Feb 15; 142(2):413-23. PubMed ID: 8382008
    [Abstract] [Full Text] [Related]

  • 30. [Gene expression of growth factors, growth factor receptor and oncogenes in human lung cancer cell lines].
    Chen J, Liu T, Cui Q.
    Zhonghua Bing Li Xue Za Zhi; 1995 Feb 15; 24(1):25-8. PubMed ID: 7781111
    [Abstract] [Full Text] [Related]

  • 31. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.
    Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD.
    Nature; 1995 Feb 15; 318(6041):69-73. PubMed ID: 2997622
    [Abstract] [Full Text] [Related]

  • 32. Genetic analysis of Raf1, Mdm2, c-Myc, Cdc25a and Cdc25b proto-oncogenes in 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang S, Söderkvist P.
    Mutat Res; 2000 Jul 20; 452(1):19-26. PubMed ID: 10894886
    [Abstract] [Full Text] [Related]

  • 33. Expression of oncogenes in human hepatoma cell lines.
    Ting LP, Jeng KS, Chou CK, Su TS, Hu CP, Wong FH, Chang HK, Chang CM.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug 20; 21(3):141-50. PubMed ID: 2854043
    [Abstract] [Full Text] [Related]

  • 34. Heterogeneous expression of oncogenes in small-cell lung-cancer xenografts.
    Arvelo F, Poupon M, Baldeyrou P, Lechevalier T.
    Int J Oncol; 1993 Apr 20; 2(4):621-5. PubMed ID: 21573601
    [Abstract] [Full Text] [Related]

  • 35. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
    Soini Y, Mannermaa A, Winqvist R, Kamel D, Poikonen K, Kiviniemi H, Pääkkö P.
    J Histochem Cytochem; 1994 Jun 20; 42(6):795-803. PubMed ID: 7910618
    [Abstract] [Full Text] [Related]

  • 36. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
    Gutman M, Ravia Y, Assaf D, Yamamoto T, Rozin R, Shiloh Y.
    Int J Cancer; 1989 Nov 15; 44(5):802-5. PubMed ID: 2573579
    [Abstract] [Full Text] [Related]

  • 37. Pattern of growth factor, proto-oncogene and carcinoembryonic antigen gene expression in human colorectal carcinoma cell lines.
    La Rocca RV, Park JG, Danesi R, Del Tacca M, Steinberg SM, Gazdar AF.
    Oncology; 1992 Nov 15; 49(3):209-14. PubMed ID: 1495747
    [Abstract] [Full Text] [Related]

  • 38. Expression of c-myc, c-raf-1, and c-Ki-ras in azaserine-induced pancreatic carcinomas and growing pancreas in rats.
    Silverman JA, Kuhlmann ET, Zurlo J, Yager JD, Longnecker DS.
    Mol Carcinog; 1990 Nov 15; 3(6):379-86. PubMed ID: 2278633
    [Abstract] [Full Text] [Related]

  • 39. Low level amplification of c-sis and c-myc in a spontaneous osteosarcoma model.
    Kochevar DT, Kochevar J, Garrett L.
    Cancer Lett; 1990 Sep 15; 53(2-3):213-22. PubMed ID: 2208081
    [Abstract] [Full Text] [Related]

  • 40. Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small-cell lung cancer.
    Graziano SL, Pfeifer AM, Testa JR, Mark GE, Johnson BE, Hallinan EJ, Pettengill OS, Sorenson GD, Tatum AH, Brauch H.
    Genes Chromosomes Cancer; 1991 Jul 15; 3(4):283-93. PubMed ID: 1683566
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.